Ca channel currents inhibited by serum from select patients with Guillain-Barré syndrome

European Neurology

Volumn 57, Issue 1, 2007, Pages 11-18

  Nakatani, Y ^a   Kawakami, K ^a   Nagaoka, T ^a   Utsunomiya, I ^a   Tanaka, K ^b   Yoshino, H ^c   Miyatake, T ^a   Hoshi, K ^a   Taguchi, K ^a  

^a SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c National Center for Global Health and Medicine   (Japan)

Author keywords

Acute inflammatory demyelinating polyneuropathy; Acute motor axonal neuropathy; Guillain Barr syndrome; Voltage dependent calcium current

Indexed keywords

IMMUNOGLOBULIN G; NERVE GROWTH FACTOR; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CLINICAL ARTICLE; ELECTROPHYSIOLOGY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; MALE; MUSCLE ACTION POTENTIAL; MUSCLE WEAKNESS; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; RAT; WHOLE CELL;

ACTION POTENTIALS; ANIMALS; CALCIUM CHANNELS; COCULTURE TECHNIQUES; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULIN G; MUSCLE CELLS; MUSCLE, SKELETAL; NEUROMUSCULAR JUNCTION; NEURONS; PATCH-CLAMP TECHNIQUES; PC12 CELLS; RATS; RATS, WISTAR; SERUM; SPINAL CORD;

EID: 33846417270     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097004     Document Type: Article

References (24)

1. Johnson D, Sato S, Quarles RH, Inuzuka T, Brady RO, Tourtellotte WW: Quantitation of the myelin-associated glycoprotein in human nervous tissue from controls and multiple sclerosis patients. J Neurochem 1986;46:1086-1093.
2. Schluep M, Steck AJ: Immunostaining of motor nerve terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease. Neurology 1988;38:1890-1892.
3. Thomas FP, Trojaborg W, Nagy C, Santoro M, Sadiq SA, Latov N, Hays AP: Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol 1991;82:378-382.
4. Hartung HP, Pollard JD, Harvey GK, Toyka KV: Immunopathogenesis and treatment of the Guillain-Barré syndrome. Muscle Nerve 1995;18:137-153.
5. + channel blocking factor in the cerebrospinal fluid. Pflugers Arch 1992;421:552-557.
6. Würz A, Brinkmeier H, Wollinsky KH, Mehrkens H-H, Kornhuber HH, Rüdel R: Cerebrospinal fluid and serum from patients with polyradiculoneuropathy have opposite effects on sodium channels. Muscle Nerve 1995;18:772-781.
7. Weber F, Rudel R, Aulkemeyer P, Brinkmeier H: Anti-GM1 antibodies can block neuronal voltage-gated sodium channels. Muscle Nerve 2000;23:1414-1420.
8. Buchwald B, Toyka KV, Zielasek J, Weishaupt A, Schweiger S, Dudel J: Neuromuscular blockade by IgG antibodies from patients with Guillan-Barré syndrome: a macro-patch-clamp study. Ann Neurol 1998;44:913-922.
9. Mintz IM, Adams ME, Bean BP: P-type calcium channels in rat central and peripheral neurons. Neuron 1992;9:85-95.
10. Ortiz N, Rosa R, Gallardo E, Illa I, Tomas J, Aubry J, Santafé M: IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release. J Neuroimmunol 2001;119:114-123.
11. Carlson RO, Masco D, Brooker G, Spiegel S: Endogenous ganglioside GM1 modulates Ltype calcium channel activity in N18 neuroblastoma cells. J Neurosci 1994;14:2272-2281.
12. 2+ influx and acetylcholine release in brain synaptosomes. Neuroreport 1997;8:2203-2207.
13. Santafé MM, Sabaté MM, Garcia N, Ortiz N, Lanuza MA, Tomas J: Changes in the neuromuscular synapse induced by an antibody against gangliosides. Ann Neurol 2005;57:396-407.
14. Asbury AK, Amason BGW, Karp HR, Mc-Farlin DF: Criteria for diagnosis of Guillan-Barré syndrome. Ann Neurol 1978;3:565-566.
15. Hadden RD, Comblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV: Electrophysiological classification of Guillan-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillan-Barré Syndrome Trial Group. Ann Neurol 1998;44:780-788.
16. Taguchi K, Ren J, Utsunomiya I, Aoyagi H, Fujita N, Ariga T, Miyatake T, Yoshino H: Neurophysiological and immunohistochemical studies on Guillan-Barré syndrome with IgG anti-GalNAc-GD1a antibodies - Effects on neuromuscular transmission. J Neurol Sci 2004;225:91-98.
17. Santoro M, Uncini A, Corbo M, Staugaitis N, Thomas FP, Hays AP: Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol 1992;31:385-390.
18. Arasaki K, Kusunoki S, Kubo N, Tamaki M: The pattern of antiganglioside antibody reactivities producing myelinated nerve conduction block in vivo. J Neurol Sci 1998;161:163-168.
19. Dilley A, Gregson NA, Hadden RDM, Smith KJ: Effects on axonal conduction of anti-ganglioside sera and sera from patients with Guillan-Barré syndrome. J Neuroimmunol 2003;139:133-140.
20. Hirota N, Kaji R, Bostock H, Shindo K, Kawasaki T, Mizutani K, Oka N, Kohara N, Saida T, Kimura J: The physiological effect of anti-GM1 antibodies on salutatory conduction and transmembrane currents in single motor axons. Brain 1997;120:2159-2169.
21. Nagado T, Arimura K, Sonoda Y, Kurono A, Horikiri Y, Kameyama A, Kameyama M, Pongs O, Osame M: Potassium current suppression in patients with peripheral nerve hyperexcitability. Brain 1999;122:2057-2066.
22. Barrett-Jolley R, Byrne N, Vincent A, Newsom-Davis J: Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell line. Pflügers Arch 1994;428:492-498.
23. Taguchi K, Utsunomiya I, Ren J, Yoshida N, Aoyagi H, Nakatani Y, Ariga T, Usuki S, Yu KY, Miyatake T: Effect of rabbit anti-asialo-GM1 (GA1) polyclonal antibodies on neuromuscular transmission and acetylcholine-induced action potentials: neurophysiological and immunohistochemical studies. Neurochem Res 2004;29:953-960.
24. Ando S, Tanaka Y, Waki H, Kon K, Iwamoto M, Fukui F: Gangliosides and sialylcholesterol as modulators of synaptic functions. Ann NY Acad Sci 1998;845:232-239.